Microalbuminuria In Nondiabetic Nonhypertensive Patient With Acute Ischemic Stroke

Introduction: Acute ischemic stroke is a leading neurological emergency associated with high morbidity and mortality. While conventional risk factors such as diabetes and hypertension are well-established, emerging evidence points to microalbuminuria as an independent predictor of adverse outcomes in stroke patients, even in those without these traditional comorbidities. Objective: To determine the frequency of microalbuminuria in non-diabetic, non-hypertensive patients presenting with acute ischemic stroke. Methods: This cross-sectional study was conducted at the Medical Unit of Isra University, Hyderabad, over a two-year period (June 2022 to June 2024). A total of 200 patients aged 18–60 years, without prior history of diabetes or hypertension, and diagnosed with acute ischemic stroke confirmed via CT brain scan, were enrolled using non-probability consecutive sampling. Microalbuminuria was assessed within 24 hours of admission. Data were analyzed using SPSS v20.0 with stratification for age and gender. Results: The mean age was 52.57 ± 9.01 years; 68% of the participants were male. The majority (79%) were above 50 years of age and from rural areas (68%). Microalbuminuria was detected in 44% of patients. It was more prevalent in males and those with normal CT scan findings, though the associations were not statistically significant (p > 0.05). Conclusion: A substantial proportion of non-diabetic, non-hypertensive patients with acute ischemic stroke exhibited microalbuminuria. This simple and cost-effective marker may aid in early risk stratification and management of stroke patients, potentially reducing complications and improving outcomes.